secwatch.observer — SEC 8-K summary
======================================

Issuer:     Envista Holdings Corp (NVST)
CIK:        0001757073
Form:       8-K
Filed at:   2022-02-09T23:59:59+00:00
Accession:  0001757073-22-000005
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Envista Q4 sales up 5.8% to $651.8M; guides FY22 core growth 6-8%, adj EBITDA margin >20%
--------------------------------------------------------------------------------

- Q4 net income $42.5M ($0.24 diluted EPS); adjusted EPS $0.46 vs $0.43 in Q4 2020.
- Full-year 2021 core sales growth 29%; Q4 core sales growth 6.6% on $651.8M revenue.
- 2022 guidance: core growth 6-8%, adjusted EBITDA margin >20%, barring significant COVID disruptions.
- Pending acquisition of Carestream Dental's IOS business expected to close in Q2 2022; excluded from guidance.
- Completed sale of KaVo Treatment Unit and Instrument business on Dec 31, 2021; results reflect continuing operations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1757073/000175707322000005/0001757073-22-000005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1757073/000175707322000005/nvst-20220209.htm
  HTML page:      https://secwatch.observer/filing/0001757073-22-000005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer